Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending FRSX Q3 2021 Earnings EPS Surprises Positive Amid PreRevenue Development Stage Catheter Precision VTAK Q1 2025 Earnings Significant EPS Miss as Stock Rises Amid Strategic Progress AFLAC Q1 2026 Earnings EPS Misses Estimates Amid Operating Challenges MSDL Q1 2026 Earnings Narrow EPS Beat in a Challenging Rate Environment SPG Q1 2026 Earnings Slight EPS Miss Amid Stable Retail Fundamentals